Business Financial Stock General News Market Updates 

Influential Players in Europe Oligonucleotide Synthesis Market: Thermo Fisher Scientific Inc., GenScript, Molecular Assemblies

Press Release

The Europe oligonucleotide synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.
The growth of the oligonucleotide synthesis market is primarily attributed to the partnerships and collaborations undertaken by the market players as well as increasing venture capital investments in pharmaceutical and biotechnology companies. However, the growth of the market is restrained by factors such as frequently changing EU regulatory policies for biotechnology industry and European biotechnology sector lacks skilled professionals. On the other hand, new product development and rising investments by pharmaceutical and biotechnology companies is likely to have a positive impact on the growth of the Europe Oligonucleotide Synthesis market in the coming years.
There are various start-up companies that are providing the products/services for the biological processes. Synthetic biology has numerous applications in the chemical, agriculture, pharmaceutical and energy sectors. Companies such as, Ginkgo Bioworks works for the organism engineering, GenScript offers gene synthesis, Benchling which operates in CAD Tools, Transcriptis which is into bioinformatics operates for cloud labs/automation, Glowee offers consumer products, among the other companies operating in the synthetic biology.
Globally, the synthetic biology has set benchmark with its innovations and the dynamic results. Global leaders in biopharmaceutical industry are investing heavily in synthetic biology. For instance, synthetic DNA manufacturer DNA Script has announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures, with additional investment from Merck Ventures BV, the corporate venture arm of Merck KGaA, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners.
Furthermore, in July 2018, Evonetix Awarded Innovate UK Funding for £1.3 million ($1.75M) Gene Synthesis Project. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University. Owing to the rising investment for the synthetic biology companies, the need and demand for the synthetic biology for the development of the new techniques may increase the market in the future years.
In 2018, the synthesized oligonucleotides segment held a largest market share of 48.2% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the reagent segment held a largest market share of 45.2% of the oligonucleotide synthesis market, by application. This segment is also expected to dominate the market in 2027 owing to availability of funds as well as supportive government policies. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the academic research institutes segment held a largest market share of 45.3% of the oligonucleotide synthesis market, by end user. This segment is also expected to dominate the market in 2027. However, the diagnostic laboratories segment is anticipated to witness the fastest growth rate of 12% during the forecast period. This higher growth rate of the segment can be attributed to the efficiency of oligonucleotides for diagnostic process.
Some of the major primary and secondary sources for western blotting included in the report are, Ludwig-Maximilians-Universität München (LMU), Technical University Munich (TUM), Association For Responsible Research And Innovation In Genome Editing (ARRIGE), Biotechnology And Biological Sciences Research Council (BBSRC), Genetically Modified Crops And Organisms (GMOs), Cancer Genomics And Advanced Therapeutics (C-CAT) and others.

Sample Copy of This Report with Full ToC @ https://www.alexareports.com/report-sample/201271

Europe Oligonucleotide Synthesis Market Report give depth study of current situation of the industry. Europe Oligonucleotide Synthesis Manufacturers are valuable source of guidance and direction for companies and individuals interested in the Industry.

The Players Mentioned in our report are: The List of Companies

1. Thermo Fisher Scientific Inc.
2. GenScript
3. Molecular Assemblies
4. Twist Biosciences
5. Evonetix
6. DNA Script
7. Nuclera Nucleics
8. Camena Bioscience
9. Synthomics
10. Ansa Biotechnologies

Discuss Our Expert Team @ https://www.alexareports.com/send-an-enquiry/201271

Reason to Buy this Report:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe oligonucleotide synthesis market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Europe oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Content
Chapter 1 about the Europe Oligonucleotide Synthesis

Chapter 2 World Market Competition Landscape

Chapter 3 Europe Oligonucleotide Synthesis Market share

Chapter 4 Supply Chain

Chapter 5 Company Details

Chapter 6 Globalization & Trade

Chapter 7 Distributors and Customers

Chapter 8 Consumption Forecast by Major Regions

Chapter 9 Europe Oligonucleotide Synthesis Market Forecast through 2024

Chapter 10 Key Success Factors and Market Conclusion

TO BE CONTINUED…

*You can glance through the list of Tables and Figures when you view the sample copy of Europe Oligonucleotide Synthesis Market.

Check Best Offer of This Report @ https://www.alexareports.com/check-discount/201271

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Europe Oligonucleotide Synthesis market based on product and application. It also provides market size and forecast till 2024 for overall Europe Oligonucleotide Synthesis market with respect to five major regions, namely; North America, Europe, Asia-Pacific, Rest of the World, which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for regions.

Also, key Europe Oligonucleotide Synthesis market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered.

This post was originally published on Food and Beverage Herald

Related posts